Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Christopher R. Logg"'
Autor:
Chien-Kuo Tai, Noriyuki Kasahara, Mark Tangney, Christopher R. Logg, Sara Collins, Akihito Inagaki, Peter F. Searle
Publikováno v:
Neuro Oncol
Early-phase clinical trials of Toca 511, a retroviral replicating vector (RRV) expressing an optimized form of yeast cytosine deaminase for prodrug activator gene therapy, showed highly promising evidence of therapeutic benefit and increased survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4696a7227afc5f0e7defd36957e6d53d
https://europepmc.org/articles/PMC7651312/
https://europepmc.org/articles/PMC7651312/
Autor:
Christopher R. Logg, Joan M. Robbins, Douglas J. Jolly, Carlos E. Ibanez, Harry E. Gruber, Kathrina Cunanan, Cynthia Burrascano, Yanzheng Liu, Noriyuki Kasahara, Amy H. Lin
Publikováno v:
Human Gene Therapy Methods. 27:59-70
We have developed retroviral replicating vectors (RRV) derived from Moloney murine gammaretrovirus with an amphotropic envelope and an encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES)-transgene cassette downstream of the env gene
Autor:
Taylor Buckley, Kei Hiraoka, Ryan Burnett, Akihito Inagaki, Christopher R. Logg, Cindy Burrascano, Douglas J. Jolly, Carlos E. Ibanez, Daniel L. Lohse, Karin Kristina Amundson, Dawn Jolson, Oscar Diago, Noriyuki Kasahara, Amy Lin, Omar D. Perez, Harry E. Gruber
Publikováno v:
Molecular Therapy. 20:1689-1698
Retroviral replicating vectors (RRVs) are a nonlytic alternative to oncolytic replicating viruses as anticancer agents, being selective both for dividing cells and for cells that have defects in innate immunity and interferon responsiveness. Tumor ce
Publikováno v:
Nucleic Acids Research
Nucleic acids research, vol 40, iss 15
Nucleic acids research, vol 40, iss 15
A vast amount of research on the regulation of gene expression has relied on plasmid reporter assays. In this study, we show that plasmids widely used for this purpose constitutively produce substantial amounts of RNA from a TATA-containing cryptic p
Publikováno v:
The Journal of Gene Medicine. 12:528-537
Background Bioluminescence imaging (BLI) permits the non-invasive quantification and localization of transduction and expression by gene transfer vectors. The tendency of tissue to attenuate light in the optical region, however, limits the sensitivit
Autor:
Carlos Cordon-Cardo, Makato Ohori, Choichiro Ozu, Christopher R. Logg, Silvia Menendez, Bernard H. Bochner, Eiji Kikuchi, Noriyuki Kasahara
Publikováno v:
Clinical Cancer Research. 13:4511-4518
Purpose: In an attempt to improve viral delivery of potentially therapeutic genes via an intravesical route, we have recently developed murine leukemia virus-based replication-competent retrovirus (RCR) vectors. Experimental Design: We evaluated the
Autor:
G.G. Gomez, C.A. Kruse, Renata Stripecke, Jill Nagashima, Nathan A. Lemp, James C. Cicciarelli, Robert Mendez, Christopher R. Logg, Noriyuki Kasahara, Kazunori Haga, Emmanuelle Faure-Kumar
Publikováno v:
Transplantation Proceedings. 38:3184-3188
Transplantation of many tissues requires histocompatibility matching of human leukocyte antigens (HLA) to prevent graft rejection, to reduce the level of immunosuppression needed to maintain graft survival, and to minimize the risk of graft-versus-ho
Publikováno v:
Clin Cancer Res
Purpose: Replication-competent retrovirus (RCR) vectors have been shown to achieve highly efficient and tumor-restricted replicative spread and gene transfer in vivo after direct intratumoral injection in a variety of primary cancer models. In this s
Publikováno v:
Current Gene Therapy. 5:655-667
As cancer gene therapy employing replication-defective vectors has met with limited clinical success, there is renewed interest in using replication-competent viruses for oncolytic virotherapy. In preclinical and clinical studies, various attenuated
Autor:
Jinha M. Park, Chien Kuo Tai, Noriyuki Kasahara, Christopher R. Logg, W. French Anderson, Michael F. Press
Publikováno v:
Human Gene Therapy. 14:789-802
Replication-competent murine leukemia virus (MLV) vectors can be engineered to achieve high efficiency gene transfer to solid tumors in vivo and tumor-restricted replication, however their safety can be further enhanced by redirecting tropism of the